Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
1.650
+0.070 (4.43%)
At close: Aug 13, 2025, 4:00 PM
1.649
-0.001 (-0.06%)
After-hours: Aug 13, 2025, 5:05 PM EDT
Zynex Market Cap
Zynex has a market cap or net worth of $49.99 million as of August 13, 2025. Its market cap has decreased by -82.37% in one year.
Market Cap
49.99M
Enterprise Value
103.39M
1-Year Change
-82.37%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since February 12, 2019, Zynex's market cap has decreased from $154.40M to $49.99M, a decrease of -67.62%. That is a compound annual growth rate of -15.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 47.90M | -81.22% |
| Dec 31, 2024 | 255.10M | -30.90% |
| Dec 29, 2023 | 369.20M | -29.14% |
| Dec 30, 2022 | 521.00M | 50.23% |
| Dec 31, 2021 | 346.80M | -25.83% |
| Dec 31, 2020 | 467.60M | 81.45% |
| Dec 31, 2019 | 257.70M | 66.90% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |